VERV Competitors & Alternatives

Compare with similar stocks in the same industry

VERV

Main Stock

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Genomics Precision Med Gene Editing
Competitive Moat: None
Core Technology Stack: CRISPR base editing, lipid nanoparticle delivery
Major Customers 1
none (pre-commercial)
Critical Suppliers 2
CRISPR technology licensors lipid nanoparticle manufacturers
Direct Ecosystem Rivals 3

Top Competitors

7 stocks in
Company Price Market Cap P/E Score Action
CRSP CRISPR Therapeutics AG
$40.61
-3.86%
$6.02B - 49 Compare
BEAM Beam Therapeutics Inc. Common Stock
$21.29
-6.75%
$2.44B - 41 Compare
NTLA Intellia Therapeutics, Inc
$10.00
+3.09%
$2.01B - 49 Compare
PRME Prime Medicine, Inc. Common Stock
$4.28
+0.24%
$996.55M - 47 Compare
SANA Sana Biotechnology, Inc. Common Stock
$1.91
-5.45%
$951.83M - 47 Compare
CRBU Caribou Biosciences, Inc. Common Stock
$0.36
-0.86%
$210.46M - 45 Compare

Data updated: Nov 16, 2026 | Industry: (SIC None)

7 stocks in this industry